Palantir Technologies (PLTR) delivered earnings and revenue surprises of +13.79% and +6.04%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
High-signal headlines only — macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Palantir Technologies (PLTR) delivered earnings and revenue surprises of +13.79% and +6.04%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Ameresco (AMRC) delivered earnings and revenue surprises of -22.22% and +10.27%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Buffett may have trimmed his conglomerate's position in this stock in recent years, but it remains an exceptional company.
Zoom Communications shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 77 to 83.
Investing.com -- Palantir Technologies on Monday reported fastest growth in sales since at least 2020 and raised its full-year 2026 revenue guidance that was well above Wall Street projections, sending its shares up more than 1% high in extended hours of trading.
Adjusted earnings were 27 cents a share. Analysts were expecting earnings of 23 cents a share. In January, Pinterest disclosed that is was laying off “less than 15%” of its workforce in a regulatory filing.
Palantir Technologies (PLTR) late Monday raised its 2026 revenue outlook following first-quarter res
The U.S. military used the company’s software in the Iran war and Venezuela raid, and the private-sector business has grown quickly.
The data analytics company now expects $7.65 billion to $7.66 billion in full-year revenue, up from its February forecast
The hosts of Morning Brew Daily made a simple argument on a recent episode that the idea of the “Ozempic economy” should be replaced with the “Mounjaro economy” now that Eli Lilly is controlling 60% of the GLP-1 market. Lilly’s Q1 2026 earnings report backs that up. Lilly’s Dominance, by the Numbers Eli Lilly (NYSE:LLY) ... Eli Lilly Captures 60% of the GLP-1 Market as Mounjaro Revenue Soars 125%
Cathie Wood's move signals that the market may be treating the spending surge as a temporary overhang on an otherwise intact long-term growth thesis.
Investing.com -- Pinterest Inc (NYSE:PINS) reported first-quarter results that exceeded Wall Street expectations, with adjusted earnings per share of $0.27 beating the analyst estimate of $0.23 by $0.04. Revenue reached $1.01 billion, surpassing the consensus estimate of $965.44 million and marking an 18% increase from $855 million in the same quarter last year.
Social commerce platform Pinterest (NYSE: PINS) reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 17.8% year on year to $1.01 billion. Guidance for next quarter’s revenue was better than expected at $1.14 billion at the midpoint, 2% above analysts’ estimates. Its non-GAAP profit of $0.27 per share was 24.7% above analysts’ consensus estimates.
Analog chips maker onsemi (NASDAQ:ON) reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales up 4.7% year on year to $1.51 billion. On top of that, next quarter’s revenue guidance ($1.59 billion at the midpoint) was surprisingly good and 3.5% above what analysts were expecting. Its non-GAAP profit of $0.64 per share was 4% above analysts’ consensus estimates.
Don't be too quick to give up on this fintech specialist.
Pinterest stock jumped late Monday after the social media company reported first-quarter results that beat expectations, with revenue sharply ahead of prior forecasts. Pinterest said that it earned an adjusted 27 cents per share for the March-ended quarter, up 17% from a year earlier. For the current quarter, Pinterest guided for sales of $1.14 billion at the midpoint of its given range.
Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) beat Wall Street’s revenue expectations in Q1 CY2026, with sales up 7.8% year on year to $2.99 billion. The company expects the full year’s revenue to be around $13.03 billion, close to analysts’ estimates. Its non-GAAP profit of $4.47 per share was 3.8% above analysts’ consensus estimates.
Pinterest forecast second-quarter revenue above analysts' estimates on Monday, helped by steady spending from advertisers as the image-sharing platform sharpens its ad offerings with deeper artificial intelligence integration. Shares of the California-based company jumped 16% in extended trading. The company has been stepping up investments in AI, rolling out enhancements to its Performance+ ad suite to automate ad creation and improve personalized targeting, which have started to bear fruit.
May 4 (Reuters) - Vertex Pharmaceuticals on Monday beat Wall Street estimates for first-quarter adjusted profit, helped by a near eight-fold surge in sales of its new cystic fibrosis treatment.
The Street is bullish on this biotech's prospects, but is the sentiment justified?
Major digital assets rose Monday with Bitcoin (BTC-USD) topping $79,000. The CoinDesk Market Inde
AMD reported its first quarter earnings on Tuesday.
AMD reported its first quarter earnings on Tuesday.
Our 24/7 Wall St. price target for Ford (NYSE:F) is $14.59 over the next 12 months, implying 22.78% upside from the current price of $11.88. Our recommendation is buy, with a confidence level of 90%. Ford’s raised full-year guidance, expanding Ford Pro software base, and deeply discounted forward multiple form the foundation of our call. ... Ford Stock Poised for 22% Jump
Investors think a new addition to the biotech's pipeline could be the next catalyst.
Most investors are comfortable buying the S&P 500 when the markets are heading higher. Buying when it's falling is where the real money can be made.
Micron stands out in a profitability-driven market shift, boasting a 41.5% net margin and massive share gains as investors hunt for strong earnings performers.
Salesforce is under pressure, but its bold AI-driven overhaul signals a strategic reset that could redefine its growth story and reignite investor confidence.